DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

Information source: GlaxoSmithKline
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Restless Legs Syndrome

Intervention: ropinirole Extended Release (XR) (Drug)

Phase: Phase 3

Status: Active, not recruiting

Sponsored by: GlaxoSmithKline

Official(s) and/or principal investigator(s):
GSK Clinical trials, MD, Study Director, Affiliation: GlaxoSmithKline

Summary

Restless Legs Syndrome (RLS) study in adults comparing immediate release ropinirole with extended release ropinirole over 12 weeks

Clinical Details

Official title: A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)

Study design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: To demonstrate the superior tolerability of ropinirole extended release compared to ropinirole immediate release in adult subjects with RLS requiring evening and night-time coverage of RLS symptoms

Secondary outcome: To compare the safety profile and to evaluate the clinical benefits (as assessed by efficacy endpoints and patient-reported outcomes) of ropinirole extended release compared to ropinirole immediate release in subjects with RLS.

Eligibility

Minimum age: 18 Years. Maximum age: 79 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Diagnosis of primary RLS according to RLS Diagnostic Clinical Interview and

International Restless Legs Syndrome Study Group Diagnostic Criteria.

- Disturbed sleep, with both evening (between 5: 00 pm and 8: 00 pm) and night time

(between 8: 00 pm and 8: 00 am) symptoms requiring treatment.

Exclusion criteria:

- Signs of secondary RLS.

- Primary sleep disorder or movement disorder other than RLS.

- Unstable medical conditions.

- Inability to tolerate dopamine agonists or dopamine antagonists.

- Unwilling to discontinue any medications currently being taken to treat RLS symptoms.

Locations and Contacts

GSK Clinical Trials Call Centre, Kippa Ring QLD 4021, Australia

GSK Clinical Trials Call Centre, Camperdown NSW 2050, Australia

GSK Clinical Trials Call Centre, Auchenflower QLD4066, Australia

GSK Clinical Trials Call Centre, Vienna 01090, Austria

GSK Clinical Trials Call Centre, Innsbruck 06020, Austria

GSK Clinical Trials Call Centre, Edegem 02650, Belgium

GSK Clinical Trials Call Centre, Bruxelles 01190, Belgium

GSK Clinical Trials Call Centre, Liege 04000, Belgium

GSK Clinical Trials Call Centre, Charleroi 06000, Belgium

GSK Clinical Trials Call Centre, Ghent 09000, Belgium

GSK Clinical Trials Call Centre, Liege 4000, Belgium

GSK Clinical Trials Call Centre, Copenhagen 02400, Denmark

GSK Clinical Trials Call Centre, Hvidovre 02650, Denmark

GSK Clinical Trials Call Centre, Odense 05000, Denmark

GSK Clinical Trials Call Centre, Glostrup 02600, Denmark

GSK Clinical Trials Call Centre, Montpellier 34295, France

GSK Clinical Trials Call Centre, Nancy 54035, France

GSK Clinical Trials Call Centre, Lille 59037, France

GSK Clinical Trials Call Centre, Grenoble 38043, France

GSK Clinical Trials Call Centre, Paris 75908, France

GSK Clinical Trials Call Centre, Pessac 33604, France

GSK Clinical Trials Call Centre, Bordeaux 33000, France

GSK Clinical Trials Call Centre, Anzin 59410, France

GSK Clinical Trials Call Centre, CRETEIL 94010, France

GSK Clinical Trials Call Centre, MONTBRISON 42600, France

GSK Clinical Trials Call Centre, Gera 07551, Germany

GSK Clinical Trials Call Centre, Chemnitz 09111, Germany

GSK Clinical Trials Call Centre, Berlin 12163, Germany

GSK Clinical Trials Call Centre, Munchen 80331, Germany

GSK Clinical Trials Call Centre, Kothen (Anhalt) 06366, Germany

GSK Clinical Trials Call Centre, Schwerin 19053, Germany

GSK Clinical Trials Call Centre, Milan 20100, Italy

GSK Clinical Trials Call Centre, Bologna 40100, Italy

GSK Clinical Trials Call Centre, Rome 00168, Italy

GSK Clinical Trials Call Centre, Pisa 56126, Italy

GSK Clinical Trials Call Centre, Grubbenvorst 05971, Netherlands

GSK Clinical Trials Call Centre, SEIN 08000, Netherlands

GSK Clinical Trials Call Centre, Amsterdam 01066, Netherlands

GSK Clinical Trials Call Centre, Nieuwegein 3435 CM, Netherlands

GSK Clinical Trials Call Centre, Geldermalsen 04191, Netherlands

GSK Clinical Trials Call Centre, Hoogwoud 01718, Netherlands

GSK Clinical Trials Call Centre, Paradis 05231, Norway

GSK Clinical Trials Call Centre, Drammen 03004, Norway

GSK Clinical Trials Call Centre, Sandvika 01338, Norway

GSK Clinical Trials Call Centre, Orebro 70185, Sweden

GSK Clinical Trials Call Centre, Helsingborg 25221, Sweden

GSK Clinical Trials Call Centre, Gothenburg 41255, Sweden

GSK Clinical Trials Call Centre, Blackpool FY4 3AD, United Kingdom

GSK Clinical Trials Call Centre, Doncaster DN1 2EG, United Kingdom

GSK Clinical Trials Call Centre, Frome BA11 1EZ, United Kingdom

GSK Clinical Trials Call Centre, Chesterfield S40 4TF, United Kingdom

GSK Clinical Trials Call Centre, Corsham SN13 8NA, United Kingdom

GSK Clinical Trials Call Centre, Coventry CV6 4DD, United Kingdom

GSK Clinical Trials Call Center, Birmingham, Alabama 35209, United States

GSK Clinical Trials Call Center, Sun City, Arizona 85351, United States

GSK Clinical Trials Call Center, Winnetka, California 91306, United States

GSK Clinical Trials Call Center, Downey, California 90241, United States

GSK Clinical Trials Call Center, Anaheim, California 92801, United States

GSK Clinical Trials Call Center, Santa Monica, California 90404, United States

GSK Clinical Trials Call Center, Stanford, California 94305, United States

GSK Clinical Trials Call Center, Burlingame, California 94010, United States

GSK Clinical Trials Call Center, Redondo Beach, California 90277, United States

GSK Clinical Trials Call Center, Newport Beach, California 92660, United States

GSK Clinical Trials Call Center, Boca Raton, Florida 33486, United States

GSK Clinical Trials Call Center, Coeur d'Alene, Idaho 83814, United States

GSK Clinical Trials Call Center, Boston, Massachusetts 02115, United States

GSK Clinical Trials Call Center, West Yarmouth, Massachusetts 02673, United States

GSK Clinical Trials Call Center, Worcester, Massachusetts 01655, United States

GSK Clinical Trials Call Center, Springfield, Massachusetts 01104, United States

GSK Clinical Trials Call Center, St. Paul, Minnesota 55101, United States

GSK Clinical Trials Call Center, St. Louis, Missouri 63128, United States

GSK Clinical Trials Call Center, Las Vegas, Nevada 89119, United States

GSK Clinical Trials Call Center, Lebanon, New Hampshire 03766, United States

GSK Clinical Trials Call Center, Albany, New York 12205, United States

GSK Clinical Trials Call Center, Tabor City, North Carolina 28463, United States

GSK Clinical Trials Call Center, Fargo, North Dakota 58104, United States

GSK Clinical Trials Call Center, Hershey, Pennsylvania 17033, United States

GSK Clinical Trials Call Center, Warwick, Rhode Island 02886, United States

GSK Clinical Trials Call Center, Burlington, Vermont 05401, United States

GSK Clinical Trials Call Center, Kirkland, Washington 98034, United States

Additional Information

Starting date: February 2006
Last updated: September 25, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008